MARKET

SAVA

SAVA

Cassava Sciences
NASDAQ
1.398
+0.018
+1.30%
Opening 13:22 04/02 EDT
OPEN
1.357
PREV CLOSE
1.380
HIGH
1.420
LOW
1.341
VOLUME
545.43K
TURNOVER
--
52 WEEK HIGH
42.20
52 WEEK LOW
1.341
MARKET CAP
67.53M
P/E (TTM)
-2.6608
1D
5D
1M
3M
1Y
5Y
1D
Is the Future Bleak for SAVA Stock Following Another Setback?
NASDAQ · 2d ago
Weekly Report: what happened at SAVA last week (0324-0328)?
Weekly Report · 2d ago
Notable healthcare headlines for the week: J&J, GSK, Merck, and Cassava Sciences in focus
Seeking Alpha · 3d ago
Trending stocks this week as Wall Street wobbles
Seeking Alpha · 3d ago
Biotech Alert: Searches spiking for these stocks today
TipRanks · 5d ago
Biotech Stock Roundup: SAVA Dives on Setback, ALNY Up on Update & More
NASDAQ · 03/26 14:02
SAVA Stock Down as Alzheimer's Drug Fails in Second Late-Stage Study
NASDAQ · 03/26 11:43
Cassava Sciences Stock Drops Over 30% After Alzheimer’s Drug Fails Study – But Retail Remains Hopeful
Barchart · 03/25 21:12
More
About SAVA
More
Cassava Sciences, Inc. is a clinical-stage biopharmaceutical company focused on developing novel, investigational treatments for central nervous system disorders, including Alzheimer’s disease and tuberous sclerosis complex (TSC)-related seizures. The Company's science is based on stabilizing, but not removing, a critical protein in the brain for patients with disorders such as Alzheimer’s disease or TSC. It has two biopharmaceutical assets under development: Simufilam and SavaDx. Simufilam, its lead therapeutic product candidate, is an oral treatment for Alzheimer’s disease and TSC-related epilepsy. Simufilam targets an altered form of a protein called filamin A (FLNA) in the brain of patients with disorders such as Alzheimer’s disease or TSC. SavaDx, its lead investigational diagnostic product candidate, early-stage program focused on detecting the presence of Alzheimer’s disease from a small sample of blood.
Recently
Symbol
Price
%Change

Webull offers Cassava Sciences Inc stock information, including NASDAQ: SAVA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SAVA stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading SAVA stock methods without spending real money on the virtual paper trading platform.